BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34535761)

  • 1. DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia.
    Toksvang LN; Grell K; Nielsen SN; Nersting J; Murdy D; Moorman AV; Vora A; Schmiegelow K
    Leukemia; 2022 Feb; 36(2):555-557. PubMed ID: 34535761
    [No Abstract]   [Full Text] [Related]  

  • 2. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.
    Stoneham S; Lennard L; Coen P; Lilleyman J; Saha V
    Br J Haematol; 2003 Oct; 123(1):100-2. PubMed ID: 14510948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Wray L; Vujkovic M; McWilliams T; Cannon S; Devidas M; Stork L; Aplenc R
    Pediatr Blood Cancer; 2014 Nov; 61(11):2086-8. PubMed ID: 24737678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular hemorrhage secondary to thioguanine-associated veno-occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification.
    Bhunia N; Yeager ND; Colace SI; Buzzaco D; Bajwa RPS
    Pediatr Transplant; 2020 Feb; 24(1):e13638. PubMed ID: 31840375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
    Jacobs SS; Stork LC; Bostrom BC; Hutchinson R; Holcenberg J; Reaman GH; Erdmann G; Franklin J; Neglia JP; Steinberg SM; Balis FM; Adamson PC; ;
    Pediatr Blood Cancer; 2007 Sep; 49(3):250-5. PubMed ID: 16856155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
    Stork LC; Matloub Y; Broxson E; La M; Yanofsky R; Sather H; Hutchinson R; Heerema NA; Sorrell AD; Masterson M; Bleyer A; Gaynon PS
    Blood; 2010 Apr; 115(14):2740-8. PubMed ID: 20124218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thioguanine treatment-related sinusoidal obstruction syndrome in 2 children].
    Mao JQ; Zhao FY; Song H; Yang SL; Shen DY; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):788-90. PubMed ID: 24034928
    [No Abstract]   [Full Text] [Related]  

  • 8. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
    Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
    Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease.
    Kane S; Cohen SM; Hart J
    Inflamm Bowel Dis; 2004 Sep; 10(5):652-4. PubMed ID: 15472529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Möricke A; Buchmann S; Zimmermann M; Igel S; Schmiegelow K; Flotho C; Hartmann H; Illsinger S; Sauerbrey A; Junk SV; Schütte P; Hinze L; Lauten M; Modlich S; Kolb R; Rossig C; Schwabe G; Gnekow AK; Fleischhack G; Schlegel PG; Schünemann HJ; Kratz CP; Cario G; Schrappe M; Schwab M
    Leukemia; 2021 Sep; 35(9):2650-2657. PubMed ID: 33714975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Marasco G; Scaioli E; Renzulli M; Colecchia A; Golfieri R; Festi D; Bazzoli F; Digby RJ; Belluzzi A
    Am J Gastroenterol; 2016 Jun; 111(6):767. PubMed ID: 27249976
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
    Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of 6-thioguanine in the treatment of childhood acute lymphoblastic leukemia: A protocol for systematic review and meta-analysis.
    Chen L; Yan HX; Liu XW; Chen WX
    Medicine (Baltimore); 2020 May; 99(18):e20082. PubMed ID: 32358392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinusoidal Obstruction Syndrome of the Liver Associated With 6-Mercaptopurine During Maintenance in a Child With T-cell Acute Lymphoblastic Leukemia.
    Prudowsky ZD; Schafer ES; Brackett J; Herbison AB; Shapiro MC
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):e121-e123. PubMed ID: 36036518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioguanine versus mercaptopurine in childhood ALL.
    Stanulla M; Schünemann HJ
    Lancet; 2006 Oct; 368(9544):1304-6. PubMed ID: 17046444
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
    Feldman EJ
    Leuk Res; 2000 Mar; 24(3):189-91. PubMed ID: 10739000
    [No Abstract]   [Full Text] [Related]  

  • 18. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
    Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
    Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe 6-thioguanine-induced marrow aplasia in a child with acute lymphoblastic leukemia and inherited thiopurine methyltransferase deficiency.
    McBride KL; Gilchrist GS; Smithson WA; Weinshilboum RM; Szumlanski CL
    J Pediatr Hematol Oncol; 2000; 22(5):441-5. PubMed ID: 11037857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.